Daniel earned a Ph.D. degree in Pharmaceutical Sciences at Northeastern University (USA, 2018). He currently works as a postdoctoral associate at the Koch Institute for Integrative Cancer Research, MIT. His research focuses on designing layer-by-layer nanoparticles loaded with chemotherapeutics and siRNA for the treatment of adenoid cystic carcinoma. Daniel was a grantee of Science without Borders Scholarship Program, CAPES, Brazil.